Direct sGC Activation Bypasses NO Scavenging Reactions of Intravascular Free Oxy-Hemoglobin and Limits Vasoconstriction

被引:23
作者
Raat, Nicolaas J. H. [1 ,2 ]
Tabima, D. Marcela [2 ]
Specht, Patricia A. C. [1 ]
Tejero, Jesus [2 ]
Champion, Hunter C. [2 ,3 ]
Kim-Shapiro, Daniel B. [4 ,5 ]
Baust, Jeff [2 ]
Mik, Egbert G. [1 ]
Hildesheim, Mariana [3 ]
Stasch, Johannes-Peter [6 ,7 ]
Becker, Eva-Maria [6 ,8 ]
Truebel, Hubert [6 ,8 ]
Gladwin, Mark T. [2 ,3 ]
机构
[1] Erasmus MC Univ Med Ctr Rotterdam, Dept Anesthesiol, Lab Expt Anesthesiol, NL-3015 GE Rotterdam, Netherlands
[2] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA
[4] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA
[5] Wake Forest Univ, Translat Sci Ctr, Winston Salem, NC 27109 USA
[6] Bayer Pharma AG, Wuppertal, Germany
[7] Univ Halle Wittenberg, Inst Pharm, D-06108 Halle, Germany
[8] Univ Witten Herdecke, Dept Human Med, Witten, Germany
关键词
SOLUBLE GUANYLATE-CYCLASE; CELL-FREE HEMOGLOBIN; SYSTEMIC VASODILATOR RESPONSES; OXIDE-INDEPENDENT ACTIVATION; NITRIC-OXIDE; PULMONARY-HYPERTENSION; THERAPEUTIC TARGET; PLASMA HEMOGLOBIN; BAY; 60-2770; CYCLIC-GMP;
D O I
10.1089/ars.2013.5181
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aims: Hemoglobin-based oxygen carriers (HBOC) provide a potential alternative to red blood cell (RBC) transfusion. Their clinical application has been limited by adverse effects, in large part thought to be mediated by the intravascular scavenging of the vasodilator nitric oxide (NO) by cell-free plasma oxy-hemoglobin. Free hemoglobin may also cause endothelial dysfunction and platelet activation in hemolytic diseases and after transfusion of aged stored RBCs. The new soluble guanylate cyclase (sGC) stimulator Bay 41-8543 and sGC activator Bay 60-2770 directly modulate sGC, independent of NO bioavailability, providing a potential therapeutic mechanism to bypass hemoglobin-mediated NO inactivation. Results: Infusions of human hemoglobin solutions and the HBOC Oxyglobin into rats produced a severe hypertensive response, even at low plasma heme concentrations approaching 10M. These reactions were only observed for ferrous oxy-hemoglobin and not analogs that do not rapidly scavenge NO. Infusions of L-NG-Nitroarginine methyl ester (L-NAME), a competitive NO synthase inhibitor, after hemoglobin infusion did not produce additive vasoconstriction, suggesting that vasoconstriction is related to scavenging of vascular NO. Open-chest hemodynamic studies confirmed that hypertension occurred secondary to direct effects on increasing vascular resistance, with limited negative cardiac inotropic effects. Intravascular hemoglobin reduced the vasodilatory potency of sodium nitroprusside (SNP) and sildenafil, but had no effect on vasodilatation by direct NO-independent activation of sGC by BAY 41-8543 and BAY 60-2770. Innovation and Conclusion: These data suggest that both sGC stimulators and sGC activators could be used to restore cyclic guanosine monophosphate-dependent vasodilation in conditions where cell-free plasma hemoglobin is sufficient to inhibit endogenous NO signaling. Antioxid. Redox Signal. 19, 2232-2243.
引用
收藏
页码:2232 / 2243
页数:12
相关论文
共 41 条
  • [1] Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide
    Badejo, Adeleke M., Jr.
    Nossaman, Vaughn E.
    Pankey, Edward A.
    Bhartiya, Manish
    Kannadka, Chandrika B.
    Murthy, Subramanyam N.
    Nossaman, Bobby D.
    Kadowitz, Philip J.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 299 (04): : H1153 - H1159
  • [2] Pulmonary Hypertension in Lambs Transfused with Stored Blood Is Prevented by Breathing Nitric Oxide
    Baron, David M.
    Yu, Binglan
    Lei, Chong
    Bagchi, Aranya
    Beloiartsev, Arkadi
    Stowell, Christopher P.
    Steinbicker, Andrea U.
    Malhotra, Rajeev
    Bloch, Kenneth D.
    Zapol, Warren M.
    [J]. ANESTHESIOLOGY, 2012, 116 (03) : 637 - 647
  • [3] Role of endothelin-1 in the hyper-responsiveness to nitrovasodilators following acute NOS inhibition
    Bourque, Stephane L.
    Whittingham, Heather A.
    Brien, Susan E.
    Davidge, Sandra T.
    Adams, Michael A.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (06) : 1992 - 1999
  • [4] Structure and Regulation of Soluble Guanylate Cyclase
    Derbyshire, Emily R.
    Marletta, Michael A.
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81, 2012, 81 : 533 - 559
  • [5] Nitric Oxide Scavenging by Red Blood Cell Microparticles and Cell-Free Hemoglobin as a Mechanism for the Red Cell Storage Lesion
    Donadee, Chenell
    Raat, Nicolaas J. H.
    Kanias, Tamir
    Tejero, Jesus
    Lee, Janet S.
    Kelley, Eric E.
    Zhao, Xuejun
    Liu, Chen
    Reynolds, Hannah
    Azarov, Ivan
    Frizzell, Sheila
    Meyer, E. Michael
    Donnenberg, Albert D.
    Qu, Lirong
    Triulzi, Darrel
    Kim-Shapiro, Daniel B.
    Gladwin, Mark T.
    [J]. CIRCULATION, 2011, 124 (04) : 465 - U294
  • [6] OXIDATION OF NITROGEN-OXIDES BY BOUND DIOXYGEN IN HEMOPROTEINS
    DOYLE, MP
    HOEKSTRA, JW
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 1981, 14 (04) : 351 - 358
  • [7] Pulmonary hypertension as a risk factor for death in patients with sickle cell disease
    Gladwin, MT
    Sachdev, V
    Jison, ML
    Shizukuda, Y
    Plehn, JF
    Minter, K
    Brown, B
    Coles, WA
    Nichols, JS
    Ernst, I
    Hunter, LA
    Blackwelder, WC
    Schechter, AN
    Rodgers, GP
    Castro, O
    Ognibene, FP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (09) : 886 - 895
  • [8] HEIM JM, 1988, Z KARDIOL, V77, P41
  • [9] Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability
    Hsu, Lewis L.
    Champion, Hunter C.
    Campbell-Lee, Sally A.
    Bivalacqua, Trinity J.
    Manci, Elizabeth A.
    Diwan, Bhalchandra. A.
    Schimel, Daniel M.
    Cochard, Audrey E.
    Wang, Xunde
    Schechter, Alan N.
    Noguchi, Constance T.
    Gladwin, Mark T.
    [J]. BLOOD, 2007, 109 (07) : 3088 - 3098
  • [10] The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model
    Hu, Weiguo
    Jin, Richard
    Zhang, Jinyan
    You, Tao
    Peng, Zhihai
    Ge, Xiaowen
    Bronson, Roderick T.
    Halperin, Jose A.
    Loscalzo, Joseph
    Qin, Xuebin
    [J]. BLOOD, 2010, 116 (09) : 1613 - 1622